[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]

February 2020 - July 1959

Decade

Year

Issue

March 2020, Vol 77, No. 3, Pages 224-328

Viewpoint

Ranking Antipsychotics for Efficacy and Safety in Schizophrenia

Abstract Full Text
JAMA Psychiatry. 2020;77(3):225-226. doi:10.1001/jamapsychiatry.2019.3377

This Viewpoint examines network meta-analyses that explore the efficacy of various antipsychotics in treating schizophrenia.

New Frontiers in Irritability Research—From Cradle to Grave and Bench to Bedside

Abstract Full Text
JAMA Psychiatry. 2020;77(3):227-228. doi:10.1001/jamapsychiatry.2019.3686

This Viewpoint discusses the brain basis for irritability across the life span in the context of the extensive burden on individuals, their families, and the public at large.

Private Equity Investment in Behavioral Health Treatment Centers

Abstract Full Text
JAMA Psychiatry. 2020;77(3):229-230. doi:10.1001/jamapsychiatry.2019.3880

This Viewpoint examines the role of private equity in behavioral health care in the United States.

Editorial

Relapse Prevention After Recovery in Patients With Persistent Major Depressive Disorder—An Active Pursuit

Abstract Full Text
JAMA Psychiatry. 2020;77(3):231-232. doi:10.1001/jamapsychiatry.2019.3637

Income Inequality and Psychiatric Admission in a Rich Country: Happiness Does Not Guarantee Mental Health Equity

Abstract Full Text
JAMA Psychiatry. 2020;77(3):233-234. doi:10.1001/jamapsychiatry.2019.3638

The Importance of Sleep Phenotypes in Bipolar Disorders

Abstract Full Text
JAMA Psychiatry. 2020;77(3):235-236. doi:10.1001/jamapsychiatry.2019.3747
Original Investigation

Prevention of Recurrence After Recovery From a Major Depressive Episode With Antidepressant Medication Alone or in Combination With Cognitive Behavioral Therapy: Phase 2 of a 2-Phase Randomized Clinical Trial

Abstract Full Text
has active quiz
JAMA Psychiatry. 2020;77(3):237-245. doi:10.1001/jamapsychiatry.2019.3900

This phase 2 randomized clinical trial investigates the effect of treatment with cognitive behavioral therapy, administered with antidepressant medication, on recurrence prevention when medication treatment is maintained or withdrawn after recovery in adults with major depressive disorder.

Effects of Mirtazapine for Methamphetamine Use Disorder Among Cisgender Men and Transgender Women Who Have Sex With Men: A Placebo-Controlled Randomized Clinical Trial

Abstract Full Text
JAMA Psychiatry. 2020;77(3):246-255. doi:10.1001/jamapsychiatry.2019.3655

This randomized clinical trial assesses the efficacy of mirtazapine for treatment of methamphetamine use disorder and reduction in HIV risk behaviors among cisgender men and transgender women.

Economic Evaluation of Brief Cognitive Behavioral Therapy vs Treatment as Usual for Suicidal US Army Soldiers

Abstract Full Text
JAMA Psychiatry. 2020;77(3):256-264. doi:10.1001/jamapsychiatry.2019.3639

This economic evaluation compares the use of brief cognitive behavioral therapy with the usual treatment given in suicidal US Army soldiers.

Long-term Outcomes of Cognitive Behavioral Therapy for Anxiety-Related Disorders: A Systematic Review and Meta-analysis

Abstract Full Text
JAMA Psychiatry. 2020;77(3):265-273. doi:10.1001/jamapsychiatry.2019.3986

This systematic review and meta-analysis of 69 randomized clinical trials assesses long-term outcomes after cognitive behavioral therapy for anxiety disorders, posttraumatic stress disorder, and obsessive-compulsive disorder.

Association of Income With the Incidence Rates of First Psychiatric Hospital Admissions in Finland, 1996-2014

Abstract Full Text
JAMA Psychiatry. 2020;77(3):274-284. doi:10.1001/jamapsychiatry.2019.3647

This cohort study compares income-specific trends in the incidence rates of first psychiatric hospital admissions and evaluates whether an income gradient exists in the incidence rates at all levels of household income among adults in Finland.

Association of Maternal Eating Disorders With Pregnancy and Neonatal Outcomes

Abstract Full Text
JAMA Psychiatry. 2020;77(3):285-293. doi:10.1001/jamapsychiatry.2019.3664

This population-based cohort study investigates the relative risk of adverse pregnancy and neonatal outcomes among Swedish women with eating disorders.

Association of Patient Treatment Preference With Dropout and Clinical Outcomes in Adult Psychosocial Mental Health Interventions: A Systematic Review and Meta-analysis

Abstract Full Text
JAMA Psychiatry. 2020;77(3):294-302. doi:10.1001/jamapsychiatry.2019.3750

This systematic review and meta-analysis assesses the association of patient treatment preference with dropout and clinical outcomes in adult psychosocial mental health interventions.

Comparison of Genetic Liability for Sleep Traits Among Individuals With Bipolar Disorder I or II and Control Participants

Abstract Full Text
open access
JAMA Psychiatry. 2020;77(3):303-310. doi:10.1001/jamapsychiatry.2019.4079

This case-control study uses a genome-wide association study and mendelian randomization to ascertain whether polygenic risk scores for sleep traits are associated with individuals with bipolar disorder I or II vs control participants.

Review

Clinical Validity of DSM-5 Attenuated Psychosis Syndrome: Advances in Diagnosis, Prognosis, and Treatment

Abstract Full Text
JAMA Psychiatry. 2020;77(3):311-320. doi:10.1001/jamapsychiatry.2019.3561

This advances in diagnosis, prognosis, and treatment review examines current evidence on the clinical validity of DSM-5 attenuated psychosis syndrome.

Research Letter

Absence of Autoantibodies Against Neuronal Surface Antigens in Sera of Patients With Psychotic Disorders

Abstract Full Text
JAMA Psychiatry. 2020;77(3):322-325. doi:10.1001/jamapsychiatry.2019.3679

This study examines the prevalence of autoantibodies against neuronal surface antigens in the sera of individuals with psychotic disorders compared with control participants.

Comment & Response

The Elusive Nature of Delay Discounting as a Transdiagnostic Process in Psychiatric Disorders—The Devil Is in the Detail

Abstract Full Text
JAMA Psychiatry. 2020;77(3):325. doi:10.1001/jamapsychiatry.2019.4121

The Elusive Nature of Delay Discounting as a Transdiagnostic Process in Psychiatric Disorders—The Devil Is in the Detail—Reply

Abstract Full Text
JAMA Psychiatry. 2020;77(3):325-326. doi:10.1001/jamapsychiatry.2019.4124

Limited Conclusions Can Be Reached From Danish Randomized Clinical Trial of Supported Employment

Abstract Full Text
JAMA Psychiatry. 2020;77(3):326-327. doi:10.1001/jamapsychiatry.2019.4177

Limited Conclusions Can Be Reached From Danish Randomized Clinical Trial of Supported Employment—Reply

Abstract Full Text
JAMA Psychiatry. 2020;77(3):327-328. doi:10.1001/jamapsychiatry.2019.4180
Correction

Error in Figure 2 Curves and Revisions to Subtitle, Abstract, and Figure Titles and Captions

Abstract Full Text
free access
JAMA Psychiatry. 2020;77(3):328. doi:10.1001/jamapsychiatry.2019.4878

Error in Surname of Contributing Author

Abstract Full Text
free access
JAMA Psychiatry. 2020;77(3):328. doi:10.1001/jamapsychiatry.2019.4578

Error in Quiz Answer

Abstract Full Text
free access
JAMA Psychiatry. 2020;77(3):328. doi:10.1001/jamapsychiatry.2019.4637
JAMA Psychiatry Masthead

JAMA Psychiatry

Abstract Full Text
free access
JAMA Psychiatry. 2020;77(3):224. doi:10.1001/jamapsychiatry.2019.2790
×